The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Changes of Intestinal Functions in Liver Cirrhosis
Open accessAbstract
Background: Understanding of the gut-liver axis is important for the up-to-date management of liver cirrhosis, and changes of intestinal functions form the core of this interesting research field. Summary: Most investigators noted small intestinal dysmotility in their patients with liver cirrhosis. Marked changes in the contraction pattern were observed in early manometric studies. The orocecal transit time, particularly small intestinal transit, has generally been reported to be prolonged, which has been demonstrated in multiple investigations to be related to the severity of the liver disease (e.g., Child-Pugh class), the presence of small intestinal bacterial overgrowth (SIBO) and hepatic encephalopathy (HE) as well as a history of spontaneous bacterial peritonitis. Bacteriologically proven SIBO in proximal jejunal aspiration has been reported to be present in up to 59% of cirrhotic patients and is associated with systemic endotoxemia. Clinical and experimental studies suggest that delayed small bowel transit in liver cirrhosis may lead to SIBO, which could contribute to the symptoms of abdominal pain and diarrhea. In addition to autonomic neuropathy, metabolic derangements and diabetic state, SIBO itself may delay intestinal transit in cirrhotic patients. Several studies, both from the West and the East, have shown that the gut microbiota is altered in cirrhotic patients and particularly those with HE. Further, a quantitative change in Bacteroides/Firmicutes ratio, with a prevalence of potentially pathogenic bacteria (e.g., Enterobacteriaceae) and reduction in specific commensals (e.g., Lachnospiraceae), has been described. Structural and functional changes in the intestinal mucosa that contribute to increases in intestinal permeability for bacteria and their products have been observed in patients with liver cirrhosis, which is considered as an important pathogenetic factor for several complications. The mechanism of intestinal barrier dysfunction in cirrhosis is multifactorial, including alcohol, portal hypertension (vascular congestion and dysregulation), endotoxemia, SIBO, local inflammation and, most likely, immunological factors and medications. Key Messages: This review summarizes major achievements regarding intestinal dysfunction in cirrhosis for future gastroenterology research. The question of whether this intestinal barrier dysfunction is accompanied and/or at least partly caused by structural and functional changes in the epithelial tight junction proteins is as yet unsolved. Development of new strategies to modulate gut-liver interaction is urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
The interaction between bacteria and bile
Begley, M., Gahan, C. G. M., & Hill, C. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.09.003 · Cited by 1,790
Prognostic impact of disease-related malnutrition
Norman, K., Pichard, C., Lochs, H., & Pirlich, M. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2007.10.007 · Cited by 1,507
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136
Research works printed but not linked: 16
- 10.1046/j.1440-1746.2002.02877.x · doi:10.1046/j.1440-1746.2002.02877.x
- 10.5754/hge11602 · doi:10.5754/hge11602
- 10.1097/00004836-200302000-00017 · doi:10.1097/00004836-200302000-00017
- 10.1007/BF02996298 · doi:10.1007/bf02996298
- 10.1136/gut.37.4.488 · doi:10.1136/gut.37.4.488
- 10.1111/j.1600-0676.1992.tb00577.x · doi:10.1111/j.1600-0676.1992.tb00577.x
- 10.1016/S0168-8278(05)80127-8 · doi:10.1016/s0168-8278(05)80127-8
- 10.1136/gut.36.5.654 · doi:10.1136/gut.36.5.654
- 10.1096/fj.04-3325fje · doi:10.1096/fj.04-3325fje
- 10.1016/S1091-255X(00)80086-4 · doi:10.1016/s1091-255x(00)80086-4
- 10.1007/s10620-006-9139-8 · doi:10.1007/s10620-006-9139-8
- 10.1097/00042737-200606000-00012 · doi:10.1097/00042737-200606000-00012
- 10.1111/j.1572-0241.2007.01536.x · doi:10.1111/j.1572-0241.2007.01536.x
- 10.1097/MCG.0b013e318038d312 · doi:10.1097/mcg.0b013e318038d312
- 10.1042/bj2100957 · doi:10.1042/bj2100957
- 10.1111/j.1440-1746.1996.tb00325.x · doi:10.1111/j.1440-1746.1996.tb00325.x
Cited by
Items 401–500 of 768
The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health
De Filippis, F., Pasolli, E., & Ercolini, D. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa015 · Cited by 303
The impact of rearing environment on the development of gut microbiota in tilapia larvae
Giatsis, C., Sipkema, D., Smidt, H., Heilig, H., Benvenuti, G., Verreth, J., & Verdegem, M. (2015) · Scientific Reports · doi:10.1038/srep18206 · Cited by 301
Yu, Z., Wang, Y., Lu, J., Bond, P. L., & Guo, J. (2021) · The ISME Journal · doi:10.1038/s41396-021-00909-x · Cited by 300
Nitric oxide in liver diseases
Iwakiri, Y., & Kim, M. Y. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.05.001 · Cited by 300
Learning representations of microbe–metabolite interactions
Morton, J. T., Aksenov, A. A., Nothias, L. F., Foulds, J. R., Quinn, R. A., Badri, M. H., Swenson, T. L., Van Goethem, M. W., Northen, T. R., Vazquez-Baeza, Y., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0616-3 · Cited by 299
Mutlu, E. A., Comba, I. Y., Cho, T., Engen, P. A., Yazıcı, C., Soberanes, S., Hamanaka, R. B., Niğdelioğlu, R., Meliton, A. Y., Ghio, A. J., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.04.130 · Cited by 296
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature
Khan, M. J., Gerasimidis, K., Edwards, C. A., & Shaikh, M. G. (2016) · Journal of Obesity · doi:10.1155/2016/7353642 · Cited by 295
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
Kim, D. H., & Cheon, J. H. (2017) · Immune Network · doi:10.4110/in.2017.17.1.25 · Cited by 295
Interplay between the gut-brain axis, obesity and cognitive function
Agustí, A., García-Pardo, M. P., López-Almela, I., Campillo, I., Maes, M., Romaní-Pérez, M., & Sanz, Y. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00155 · Cited by 294
The prenatal gut microbiome: are we colonized with bacteria in utero ?
Walker, R. W., Clemente, J. C., Peter, I., & Loos, R. J. F. (2017) · Pediatric Obesity · doi:10.1111/ijpo.12217 · Cited by 293
Bridging intestinal immunity and gut microbiota by metabolites
Wang, G., Huang, S., Wang, Y., Cai, S., Yu, H., Liu, H., Zeng, X., Zhang, G., & Qiao, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03190-6 · Cited by 293
Zhao, Q., Xing, F., Tao, Y., Liu, H., Huang, K., Peng, Y., Feng, N., & Liu, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00001 · Cited by 293
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Sangro, B., Chan, S. L., Meyer, T., Reig, M., El-Khoueiry, A., & Galle, P. R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.021 · Cited by 293
The microbiota–gut–brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?
De Palma, G., Collins, S. M., Bercik, P., & Verdu, E. F. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.273995 · Cited by 293
Fricke, W. F., Seedorf, H., Henne, A., Krüer, M., Liesegang, H., Hedderich, R., Gottschalk, G., & Thauer, R. K. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.2.642-658.2006 · Cited by 293
Gut microbiota as a source of novel antimicrobials
Garcia-Gutierrez, E., Mayer, M. J., Cotter, P. D., & Narbad, A. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1455790 · Cited by 292
Diabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
Uusitalo, U., Liu, X., Yang, J., Aronsson, C. A., Hummel, S., Butterworth, M., Lernmark, Å., Rewers, M., Hagopian, W., She, J.-X., et al. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.2757 · Cited by 292
Carroll, I. M., Ringel-Kulka, T., Keku, T. O., Chang, Y.-H., Packey, C. D., Sartor, R. B., & Ringel, Y. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00154.2011 · Cited by 292
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection
Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291
A faecal microbiota signature with high specificity for pancreatic cancer
Kartal, E., Schmidt, T. S. B., Molina-Montes, E., Rodríguez-Perales, S., Wirbel, J., Maistrenko, O. M., Akanni, W. A., Alashkar Alhamwe, B., Alves, R. J., Carrato, A., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-324755 · Cited by 290
Shandilya, S., Kumar, S., Kumar Jha, N., Kumar Kesari, K., & Ruokolainen, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.005 · Cited by 290
Söderholm, J. D., Olaison, G., Peterson, K. H., Franzén, L. E., Lindmark, T., Wirén, M., Tagesson, C., & Sjödahl, R. (2002) · Gut · doi:10.1136/gut.50.3.307 · Cited by 289
Chakaroun, R., Massier, L., & Kovacs, P. (2020) · Nutrients · doi:10.3390/nu12041082 · Cited by 289
Vallianou, N., Christodoulatos, G. S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., & Dalamaga, M. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 289
Casén, C., Vebø, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., Dzankovic, S., Frøyland, C., Nestestog, R., Engstrand, L., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13236 · Cited by 289
The Role of Microbiome in Insomnia, Circadian Disturbance and Depression
Li, Y., Hao, Y., Fan, F., & Zhang, B. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00669 · Cited by 288
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability
Luther, J., Garber, J. J., Khalili, H., Dave, M., Bale, S. S., Jindal, R., Motola, D. L., Luther, S., Bohr, S., Jeoung, S. W., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.001 · Cited by 286
Intestinal epithelial cells: At the interface of the microbiota and mucosal immunity
Soderholm, A. T., & Pedicord, V. A. (2019) · Immunology · doi:10.1111/imm.13117 · Cited by 281
The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure
Triantafyllou, E., Woollard, K. J., McPhail, M. J. W., Antoniades, C. G., & Possamai, L. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02948 · Cited by 285
The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
An, L., Wirth, U., Koch, D., Schirren, M., Drefs, M., Koliogiannis, D., Nieß, H., Andrassy, J., Guba, M., Bazhin, A. V., et al. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05188-7 · Cited by 284
Zhang, J., Sun, Z., Jiang, S., Bai, X., Ma, C., Peng, Q., Chen, K., Chang, H., Fang, T., & Zhang, H. (2019) · mSystems · doi:10.1128/msystems.00017-19 · Cited by 282
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
Hartmann, P., Seebauer, C. T., & Schnabl, B. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12704 · Cited by 282
Manipulating the gut microbiota to maintain health and treat disease
Scott, K. P., Antoine, J.-M., Midtvedt, T., & van Hemert, S. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.25877 · Cited by 281
The Human Intestinal Microbiome: A New Frontier of Human Biology
Hattori, M., & Taylor, T. D. (2009) · DNA Research · doi:10.1093/dnares/dsn033 · Cited by 281
Interplay Between Exercise and Gut Microbiome in the Context of Human Health and Performance
Clauss, M., Gérard, P., Mosca, A., & Leclerc, M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.637010 · Cited by 280
Nonalcoholic Fatty Liver Disease
Carr, R. M., Oranu, A., & Khungar, V. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.07.003 · Cited by 280
Scazzocchio, B., Minghetti, L., & D’Archivio, M. (2020) · Nutrients · doi:10.3390/nu12092499 · Cited by 280
Rom, O., Liu, Y., Liu, Z., Zhao, Y., Wu, J., Ghrayeb, A., Villacorta, L., Fan, Y., Chang, L., Wang, L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2841 · Cited by 280
ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Aviello, G., & Knaus, U. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13428 · Cited by 278
The microbiome, immunity, and schizophrenia and bipolar disorder.
Dickerson, F., Severance, E., & Yolken, R. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.12.010 · Cited by 268
Benjamin, M. A., McKay, D. M., Yang, P.-C., Cameron, H., & Perdue, M. H. (2000) · Gut · doi:10.1136/gut.47.1.112 · Cited by 277
Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development
Wang, H. J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i11.1304 · Cited by 277
Introduction. Ecological immunology
Schulenburg, H., Kurtz, J., Moret, Y., & Siva-Jothy, M. T. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0249 · Cited by 276
The elements of life and medicines
Chellan, P., & Sadler, P. J. (2015) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2014.0182 · Cited by 274
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., Puri, P., Sterling, R. K., Luketic, V., Stravitz, R. T., Siddiqui, M. S., Fuchs, M., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12695 · Cited by 274
Tisza, M. J., & Buck, C. B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023202118 · Cited by 273
Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder
Newell, C., Bomhof, M. R., Reimer, R. A., Hittel, D. S., Rho, J. M., & Shearer, J. (2016) · Molecular Autism · doi:10.1186/s13229-016-0099-3 · Cited by 272
A metagenomic study of the gut microbiome in Behcet’s disease
Ye, Z., Zhang, N., Wu, C., Zhang, X., Wang, Q., Huang, X., Du, L., Cao, Q., Tang, J., Zhou, C., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0520-6 · Cited by 272
Nagpal, R., Wang, S., Solberg Woods, L. C., Seshie, O., Chung, S. T., Shively, C. A., Register, T. C., Craft, S., McClain, D. A., & Yadav, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02897 · Cited by 272
Ismail, N. A., Ragab, S. H., ElBaky, A. A., Shoeib, A. R. S., Alhosary, Y., & Fekry, D. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.23418 · Cited by 271
Total Parenteral Nutrition and Bowel Rest Modify the Metabolic Response to Endotoxin in Humans
FONG, Y., MARANO, M. A., BARBER, A., HE, W., MOLDAWER, L. L., BUSHMAN, E. D., COYLE, S. M., SHIRES, G. T., & LOWRY, S. F. (1989) · Annals of Surgery · doi:10.1097/00000658-198910000-00005 · Cited by 271
O. Sheridan, P., Martin, J. C., Lawley, T. D., Browne, H. P., Harris, H. M. B., Bernalier-Donadille, A., Duncan, S. H., O'Toole, P. W., P. Scott, K., & J. Flint, H. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000043 · Cited by 271
Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
Martinez, K. B., Leone, V., & Chang, E. B. (2017) · Gut Microbes · doi:10.1080/19490976.2016.1270811 · Cited by 271
Kim, Y.-K., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 271
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
Martín, R., Miquel, S., Ulmer, J., Kechaou, N., Langella, P., & Bermúdez-Humarán, L. G. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-71 · Cited by 270
Hsieh, Y.-Y., Tung, S.-Y., Pan, H.-Y., Yen, C.-W., Xu, H.-W., Lin, Y.-J., Deng, Y.-F., Hsu, W.-T., Wu, C.-S., & Li, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-18596-0 · Cited by 269
Louis, S., Tappu, R.-M., Damms-Machado, A., Huson, D. H., & Bischoff, S. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149564 · Cited by 269
Wirbel, J., Zych, K., Essex, M., Karcher, N., Kartal, E., Salazar, G., Bork, P., Sunagawa, S., & Zeller, G. (2021) · Genome Biology · doi:10.1186/s13059-021-02306-1 · Cited by 269
Shaping the Gut Microbiota by Breastfeeding: The Gateway to Allergy Prevention?
van den Elsen, L. W. J., Garssen, J., Burcelin, R., & Verhasselt, V. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00047 · Cited by 269
Engevik, M. A., Luk, B., Chang-Graham, A. L., Hall, A., Herrmann, B., Ruan, W., Endres, B. T., Shi, Z., Garey, K. W., Hyser, J. M., et al. (2019) · mBio · doi:10.1128/mbio.01087-19 · Cited by 269
Micro and nanoscale technologies in oral drug delivery
Ahadian, S., Finbloom, J. A., Mofidfar, M., Diltemiz, S. E., Nasrollahi, F., Davoodi, E., Hosseini, V., Mylonaki, I., Sangabathuni, S., Montazerian, H., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.012 · Cited by 268
The microbiota in cirrhosis and its role in hepatic decompensation
Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D. L., & Bajaj, J. S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.013 · Cited by 268
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Liu, D., Van Belleghem, J. D., de Vries, C. R., Burgener, E., Chen, Q., Manasherob, R., Aronson, J. R., Amanatullah, D. F., Tamma, P. D., & Suh, G. A. (2021) · Viruses · doi:10.3390/v13071268 · Cited by 268
Antimicrobial Activity and Resistance: Influencing Factors
Li, J., Xie, S., Ahmed, S., Wang, F., Gu, Y., Zhang, C., Chai, X., Wu, Y., Cai, J., & Cheng, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00364 · Cited by 266
Topçuoğlu, B. D., Lesniak, N. A., Ruffin, M. T., Wiens, J., & Schloss, P. D. (2020) · mBio · doi:10.1128/mbio.00434-20 · Cited by 266
Guidelines for the investigation of chronic diarrhoea, 2nd edition
Thomas, P. D., Forbes, A., Green, J., Howdle, P., Long, R., Playford, R., Sheridan, M., Stevens, R., Valori, R., Walters, J., et al. (2003) · Gut · doi:10.1136/gut.52.suppl_5.v1 · Cited by 266
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
Bultman, S. J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500902 · Cited by 265
Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders
Metwaly, A., Reitmeier, S., & Haller, D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00581-2 · Cited by 264
Probiotics and chronic kidney disease
Koppe, L., Mafra, D., & Fouque, D. (2015) · Kidney International · doi:10.1038/ki.2015.255 · Cited by 264
Borrelli, L., Coretti, L., Dipineto, L., Bovera, F., Menna, F., Chiariotti, L., Nizza, A., Lembo, F., & Fioretti, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-16560-6 · Cited by 263
Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., & Jin, F. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00033 · Cited by 263
Paganini, D., & Zimmermann, M. B. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.156067 · Cited by 262
Merker, M., Felder, M., Gueissaz, L., Bolliger, R., Tribolet, P., Kägi-Braun, N., Gomes, F., Hoess, C., Pavlicek, V., Bilz, S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0663 · Cited by 262
Emerging Functions of Regulatory T Cells in Tissue Homeostasis
Sharma, A., & Rudra, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00883 · Cited by 262
Microbiota in the Gastrointestinal Tract
Dieterich, W., Schink, M., & Zopf, Y. (2018) · Medical Sciences · doi:10.3390/medsci6040116 · Cited by 262
Ketogenic Diet and Microbiota: Friends or Enemies?
Paoli, A., Mancin, L., Bianco, A., Thomas, E., Mota, J. F., & Piccini, F. (2019) · Genes · doi:10.3390/genes10070534 · Cited by 262
He, J., Xu, S., Zhang, B., Xiao, C., Chen, Z., Si, F., Fu, J., Lin, X., Zheng, G., Yu, G., et al. (2020) · Aging · doi:10.18632/aging.103168 · Cited by 258
The Role of the Microbiome in Asthma: The Gut–Lung Axis
Frati, F., Salvatori, C., Incorvaia, C., Bellucci, A., Di Cara, G., Marcucci, F., & Esposito, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010123 · Cited by 261
Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies
Huang, T.-T., Lai, J.-B., Du, Y.-L., Xu, Y., Ruan, L.-M., & Hu, S.-H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00098 · Cited by 261
Respiratory disease following viral lung infection alters the murine gut microbiota
Groves, H. T., Cuthbertson, L., James, P., Moffatt, M. F., Cox, M. J., & Tregoning, J. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00182 · Cited by 258
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259
Gut Microbiota and Metabolic Disorders
Hur, K. Y., & Lee, M.-S. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.3.198 · Cited by 259
MacFabe, D. F. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.28177 · Cited by 259
Ma, Z., Zuo, T., Frey, N., & Rangrez, A. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01946-6 · Cited by 259
Shao, T., Zhao, C., Li, F., Gu, Z., Liu, L., Zhang, L., Wang, Y., He, L., Liu, Y., Liu, Q., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.021 · Cited by 258
Caccialanza, R., Laviano, A., Lobascio, F., Montagna, E., Bruno, R., Ludovisi, S., Corsico, A. G., Di Sabatino, A., Belliato, M., Calvi, M., et al. (2020) · Nutrition · doi:10.1016/j.nut.2020.110835 · Cited by 258
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Cytlak, U. M., Dyer, D. P., Honeychurch, J., Williams, K. J., Travis, M. A., & Illidge, T. M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00568-1 · Cited by 258
Intestinal permeability, leaky gut, and intestinal disorders
Hollander, D. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0023-5 · Cited by 258
Methods to determine intestinal permeability and bacterial translocation during liver disease
Wang, L., Llorente, C., Hartmann, P., Yang, A.-M., Chen, P., & Schnabl, B. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.12.015 · Cited by 257
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
Singh, S., Osna, N. A., & Kharbanda, K. K. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6549 · Cited by 257
Salguero, M., Al‑Obaide, M., Singh, R., Siepmann, T., & Vasylyeva, T. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7943 · Cited by 257
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
Zhang, Q., Ma, C., Duan, Y., Heinrich, B., Rosato, U., Diggs, L. P., Ma, L., Roy, S., Fu, Q., Brown, Z. J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0304 · Cited by 257
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
Acharya, C., Sahingur, S. E., & Bajaj, J. S. (2017) · JCI Insight · doi:10.1172/jci.insight.94416 · Cited by 256
Williams, B., Grant, L., Gidley, M., & Mikkelsen, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102203 · Cited by 256
Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
Wei, X., Tao, J., Xiao, S., Jiang, S., Shang, E., Zhu, Z., Qian, D., & Duan, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22094-2 · Cited by 256
Microbial ecology and host-microbiota interactions during early life stages
Collado, M. C., Cernada, M., Baüerl, C., Vento, M., & Pérez-Martínez, G. (2012) · Gut Microbes · doi:10.4161/gmic.21215 · Cited by 256
Dose Adjustment in Patients with Liver Disease
Delc??, F., Tchambaz, L., Schlienger, R., Drewe, J., & Kr??henb??hl, S. (2005) · Drug Safety · doi:10.2165/00002018-200528060-00005 · Cited by 256
Gut microbiome in chronic kidney disease: challenges and opportunities
Nallu, A., Sharma, S., Ramezani, A., Muralidharan, J., & Raj, D. (2017) · Translational Research · doi:10.1016/j.trsl.2016.04.007 · Cited by 255
Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study
researchers, O. B. O. T. P., Planas, M., Álvarez-Hernández, J., León-Sanz, M., Celaya-Pérez, S., Araujo, K., & García de Lorenzo, A. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-015-2813-7 · Cited by 255
Metadata
- Authors
- Fukui, H., & Wiest, R.
- Venue
- Inflammatory Intestinal Diseases
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 1
- Issue
- 1
- Pages
- 24-40
- ISSN
- 2296-9365 (ISSN-L)
- 2296-9403
- OpenAlex
- W2328023807
- Cited by
- 6,808
- References
- 200
- FWCI
- 440.60
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.